Significant epilepsy gene discovery in dogs
A collaborative study describes a novel myoclonic epilepsy syndrome in dogs for the first time and discovers its genetic cause at DIRAS1 gene.
List view / Grid view
News
Janssen and GSK provide keynote addresses at Controlled Release Delivery 2017
Returning to Central London for the 14th year, SMi’s Controlled Release Delivery conference will take place on the 3rd & 4th of April 2017...
Liverpool head and neck cancer research gets £200k boost
A research project, based out of the University of Liverpool, which will bring together a multidisciplinary team of cancer surgeons, medical oncologists and scientists in Liverpool, has been given the go ahead thanks to £200,000 worth of grant funding.
Cell death research shows promise for preventing Alzheimer’s
Alzheimer’s disease is a progressive neurodegenerative disorder that leads to dementia via advanced neuronal dysfunction and death. Currently, the predominant theory behind Alzheimer’s disease is the “amyloid hypothesis,” which states that abnormally increased levels of amyloid beta (Aβ) peptides outside of brain cells produce a variety of low molecular weight…
Mitochondrial lipids as potential targets for Parkinson’s disease
Using flies, mice and patient cells, the team focused on cardiolipin, a fat unique to cells’ mitochondria, organelles that produce energy.
Orion research foundation grants €1 million for research
Orion and Finland are both celebrating their centenaries in 2017.
Quotient Clinical announces second US acquisition: QS Pharma
Quotient Clinical announces that it has acquired QS Pharma from Charles River Laboratories International, Inc...
Genetic study identifies new form of congenital muscular dystrophy
Scientists have discovered a new form of congenital muscular dystrophy caused by mutations in a previously un-linked gene.
Positive results for Viking’s rare diseases in vivo study
Viking Therapeutics announced positive initial results from a proof-of-concept study of VK2809 in an in vivo model of glycogen storage disease Ia (GSD Ia).
£100 million for Cancer Research’s ‘grand challenge’ competition winners
Cancer Research UK announced that four international teams are the first recipients of its global £100m Grand Challenge competition, which aims to overcome the biggest challenges facing cancer researchers in a global effort to beat cancer sooner.
Orexin as a potential drug for treating septic shock
Recent findings by Japanese scientists may be a breakthrough in developing a silver bullet for the treatment of septic shock.
Wellcome Trust gives Polyphor CHF 2.3 million for antibiotic development
Polyphor has received a CHF 2.3 million award from the Wellcome Trust to advance the development of broad-spectrum, Gram-negative pre-clinical product candidates.
BMBF funds Zika vaccine research group at LMU
The research group will explore novel approaches to vaccine development, focusing on the Zika virus.
Genmab appoints Judith Klimovsky as Chief Development Officer
The biotechnology company Genmab announced today the appointment of Judith Klimovsky, MD, as Executive Vice President and Chief Development Officer.
Molecular Devices introduces SpectraMax iD3 Multi-Mode Microplate Reader
Molecular Devices announced the launch of the new SpectraMax® iD3 Multi-Mode Microplate Reader, a cornerstone of a complete laboratory solution to help you expand the boundaries of your research capabilities...
